Atezolizumab
7 Topics Found
Drug Index
Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), small cell lung cancer (SCLC), and hepatocellular carcinoma (HCC).[2] It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1).[4] The most common side effects when used on its own include tired...
My boyfriend was diagnosed with small cell carcinoma in August while in the hospital with pneumonia. Straight out of the hospital into radiation and chemo treatments in which he was unable to finish. No one has mentioned immunotherapy to us as an alternative. His last blood work results said his count was within normal limits so would he have a chance of atezolizumab and immunotherapy helping him? He's 59 yrs old, has good appetite, already had AFib before diagnosed with cancer, has Medicare/Aid. We live in NW Tn. Is there hope for success for him? A tumor in 1 lung and lympnodes. ## My dad experienced something similar, he ended up hospitalized to manually drain fluid from congestive heart failure, and a sample of it that they analyzed was full of cancer cells. The Atezolizumab is ...
1 REPLY
Filed under
Atezolizumab
Atezolizumab
Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), small cell lung cancer (SCLC), and hepatocellular carcinoma (HCC).[2] It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1).[4] The most common side effects when used on its own include tired...
Cobimetinib
Cobimetinib, sold under the brand name Cotellic, is an anti-cancer medication used in combination with vemurafenib (Zelboraf) alone or with both vemurafenib and atezolizumab (Tecentriq) to treat melanoma.[1][5] Cobimetinib is a MEK inhibitor.[1] Cotellic, Zelboraf, and Tecentriq are all marketed by Genentech, a subsidiary of Roche.[1][5][6] The most common side effects include diarrhea, rash, nause...
Drug Index
Cobimetinib, sold under the brand name Cotellic, is an anti-cancer medication used in combination with vemurafenib (Zelboraf) alone or with both vemurafenib and atezolizumab (Tecentriq) to treat melanoma.[1][5] Cobimetinib is a MEK inhibitor.[1] Cotellic, Zelboraf, and Tecentriq are all marketed by Genentech, a subsidiary of Roche.[1][5][6] The most common side effects include diarrhea, rash, nause...
NDC Database
Tecentriq 840 mg/14ml Intravenous Injection, Solution by Genentech, Inc. ## Package Codes: 50242-918-01, 50242-918-86 ## Active Ingredients: Atezolizumab
NDC Database
Tecentriq 1200 mg/20ml Intravenous Injection, Solution by Genentech, Inc. ## Package Codes: 50242-917-01, 50242-917-86 ## Active Ingredients: Atezolizumab